000 01464cam  2200325zi 4500
0019.903242
003CaOODSP
00520221107180206
006m     o  d f      
007cr |||||||||||
008210913s2021    oncd    o    f00| 0 eng d
020 |a9780660403144
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-295/2021E-PDF
24500|aHIV and hepatitis C care and treatment services.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2021.
300 |a1 online resource (1 page) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Services de soins et de traitements liés au VIH et à l'hépatite C.
520 |a"Results from Indigenous participants in the Tracks survey of people who inject drugs (PWID) in Canada, Phase 4, 2017-2019."
650 0|aHIV infections|xTreatment|zCanada.
650 0|aHepatitis C|xTreatment|zCanada.
650 0|aIndigenous peoples|xMedical care|zCanada.
650 0|aIndigenous peoples|xSubstance use|xTreatment|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tServices de soins et de traitements liés au VIH et à l'hépatite C.|w(CaOODSP)9.903243
85640|qPDF|s587 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-295-2021-eng.pdf